Approval · Notice of Compliance 33677 · 2024
PADCEV: Notice of Compliance 33677
Issued July 19, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33677
- Date
- July 19, 2024
- Company
- Seagen Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PADCEV | Not yet assigned | — |
Medicinal ingredients
- ENFORTUMAB VEDOTIN 20 MG per VIAL
- ENFORTUMAB VEDOTIN 30 MG per VIAL